EUVIMEDEUVIMED entdecken
Multizentrische Studie

Potential performance of a 0 h/1 h algorithm and a single cut-off measure of high-sensitivity troponin T in a diverse population: main results of the IN-HOPE study

Pedro G M de Barros E Silva iD, Ana Amaral Ferreira, Felipe Malafaia, Antonielle Figueiredo Macedo Tavares Reis, Henry Sznejder, Augusto Celso De Araujo Lopes Junior, Camila Anacleto Agostinho, Luiz Henrique de Oliveira Fonseca, Débora Vieira Donini Okitoi, Celso Musa Correa, Eduardo Zincone, Marcelo Paiva Cury und 15 weitere

European Heart Journal: Acute Cardiovascular Care · 2023

DOI: 10.1093/ehjacc/zuad082 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2023. Verfasst von Pedro G M de Barros E Silva und 26 weiteren Autor:innen. Beteiligte Einrichtung: Cardiologia Americas/United Health Group, São Paulo, Brazil. Hauptthemen laut MEDLINE: Myocardial Infarction, Troponin T. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Roche Diagnostics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Chest pain is a major cause of medical evaluation at emergency department (ED) and demands observation to exclude the diagnosis of acute myocardial infarction (AMI). High-sensitivity cardiac troponin assays used as isolated measure and by 0- and 1-h algorithms are accepted as a rule-in/rule-out strategy, but there is a lack of validation in specific populations. Methods and results The IN-HOspital Program to systematizE Chest Pain Protocol (IN-HOPE study) is a multicentre study that prospectively included patients admitted to the ED due to suspected symptoms of AMI at 16 sites in Brazil. Medical decisions of all patients followed the standard approach of 0 h/3 h protocol, but, in addition, blood samples were also collected at 0 and 1 h and sent to a central laboratory (core lab) to measure high-sensitivity cardiac troponin T (hs-cTnT). To assess the theoretical performance of 0 h/1 h algorithm, troponin < 12 ng/L with a delta < 3 was considered rule-out while a value ≥ 52 or a delta ≥ 5 was considered a rule-in criterion (the remaining were considered as observation group). The main objective of the study was to assess, in a population managed by the 0 h/3 h protocol, the accuracy of 0 h/1 h algorithm overall and in groups with a higher probability of AMI. All patients were followed up for 30 days, and potential events were adjudicated. In addition to the prospective cohort, a retrospective analysis was performed assessing all patients with hs-cTnT measured during the year of 2021 but not included in the prospective cohort, regardless of the indication of the test. A total of 5.497 patients were included (583 in the prospective and 4.914 in the retrospective analysis). The prospective cohort had a mean age of 57.3 (± 14.8) and 45.6% of females with a mean HEART score of 4.0 ± 2.2. By the core lab analysis, 74.4% would be eligible for a rule-out approach (45.3% of them with a HEART score > 3) while 7.3% would fit the rule-in criteria. In this rule-out group, the negative predictive value for index AMI was 100% (99.1–100) overall and regardless of clinical scores. At 30 days, no death or AMI occurred in the rule-out group of both 0/1 and 0/3 h algorithms while 52.4% of the patients in the rule-in group (0 h/1 h) were considered as AMI by adjudication. In the observation group (grey zone) of 0 h/1 h algorithm, GRACE discriminated the risk of these patients better than HEART score. In the retrospective analysis, 1.091 patients had a troponin value of <5 ng/L and there were no cardiovascular deaths at 30 days in this group. Among all 4.914 patients, the 30-day risk of AMI or cardiovascular death increased according to the level of troponin: 0% in the group < 5 ng/L, 0.6% between 5 and 14 ng/L, 2.2% between 14 and 42 ng/L, 6.3% between 42 and 90 ng/L, and 7.7% in the level ≥ 90 ng/L.

Conclusion

In this large multicentre study, a 0 h/1 h algorithm had the potential to classify as rule-in or rule-out in almost 80% of the patients. The rule-out protocol had high negative predictive value regardless of clinical risk scores. Categories of levels of hs-cTn T also showed good accuracy in discriminating risk of the patients with a very favourable prognosis for cardiovascular death in the group with value < 5 ng/L. ClinicalTrials.gov NCT04756362

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionTroponin TFemaleHumansMiddle AgedAlgorithmsBiomarkersChest PainEmergency Service, HospitalProspective StudiesRetrospective StudiesTroponin IMaleAdultAged

Stichwörter der Autor:innen

Chest painDiagnosisTroponin

Substanzen

BiomarkersTroponin ITroponin T

Autor:innen und Institutionen

  • Cardiologia Americas/United Health Group, São Paulo, Brazil.
  • Hospital Samaritano Paulista, São Paulo, Brazil.
  • Brazilian Clinical Research Institute, São Paulo, Brazil.
  • Centro Universitário São Camilo, São Paulo, Brazil.
  • Hospital Pró-Cardíaco, Rio de Janeiro, Brazil.
  • Instituto Nacional de Cardiologia (INC), Rio de Janeiro, Brazil.

ORCID-Profile: Pedro G M de Barros E Silva

Förderung

  • Roche Diagnostics

Zitieren

APA

de Barros E Silva, P. G. M., Ferreira, A. A., Malafaia, F., Tavares Reis, A. F. M., Sznejder, H., Lopes Junior, A. C. A., Agostinho, C. A., Fonseca, L. H. O., Okitoi, D. V. D., Correa, C. M., Zincone, E., Cury, M. P., Rosa, G. A. L., Ribeiro, H. B., Soeiro, A. M., de Oliveira, C. A. L., Kuusberg, G. C., Ohe, L. N., Souza, D. O., …, & IN-HOPE Investigators (2023). Potential performance of a 0 h/1 h algorithm and a single cut-off measure of high-sensitivity troponin T in a diverse population: main results of the IN-HOPE study. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuad082

Vancouver

de Barros E Silva PGM, Ferreira AA, Malafaia F, Tavares Reis AFM, Sznejder H, Lopes Junior ACA, et al. Potential performance of a 0 h/1 h algorithm and a single cut-off measure of high-sensitivity troponin T in a diverse population: main results of the IN-HOPE study. European Heart Journal: Acute Cardiovascular Care. 2023. doi:10.1093/ehjacc/zuad082

BibTeX
@article{deBarrosESilva2023,
  author = {de Barros E Silva, Pedro G M and Ferreira, Ana Amaral and Malafaia, Felipe and Tavares Reis, Antonielle Figueiredo Macedo and Sznejder, Henry and Lopes Junior, Augusto Celso De Araujo and Agostinho, Camila Anacleto and Fonseca, Luiz Henrique de Oliveira and Okitoi, Débora Vieira Donini and Correa, Celso Musa and Zincone, Eduardo and Cury, Marcelo Paiva and Rosa, Gustavo Augusto Lopes and Ribeiro, Henrique Barbosa and Soeiro, Alexandre de Matos and de Oliveira, Carlos Alexandre Lemes and Kuusberg, Guilherme Capelli and Ohe, Louis Nakayama and Souza, Douglas de Oliveira and Manfredi, Adriana Bertolami and Martins, Amanda Francisco and Sampaio, Pedro Paulo Nogueres and Vaz, Thiago Baganha and Franco, Luciana Ferreira and Ferreira, Carlos Eduardo Dos Santos and Lopes, Renato Delascio and IN-HOPE Investigators, IN-HOPE Investigators},
  title = {Potential performance of a 0 h/1 h algorithm and a single cut-off measure of high-sensitivity troponin T in a diverse population: main results of the IN-HOPE study},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2023},
  doi = {10.1093/ehjacc/zuad082}
}
Kostenlos starten →